Health Catalyst, Inc. - Form 8-K Filing

Daniel Burton has transitioned from his role as CEO of Health Catalyst, Inc. to a strategic advisor role. This change, effective March 31, 2026, involves a monthly salary of $10,000 and concludes on December 31, 2026. As part of the agreement, Mr. Burton forfeits all unvested restricted stock units and performance-based restricted stock units eligible for vesting after March 2, 2026. He has also agreed to a general release of claims against the company. The company will provide him with continued employee benefits during this transition period. This agreement supersedes all previous employment agreements. Mr. Burton also has continuing obligations regarding confidentiality and cooperation with the company.